1.
Chimica Oggi/Chemistry Today
; 40(4):70-71, 2022.
Article
in English
| Scopus | ID: covidwho-2230974
ABSTRACT
Peter Hirst, Head of Commercial, Advanced Delivery Systems at Recipharm, discusses the fast-changing pharmaceutical market landscape and explores the latest trends driving innovation in self-administered injectable drug delivery. Some trends that are pushing growth in this area are directly linked to the COVID-19 pandemic, including the need to ease the healthcare burden. These effects will continue to be felt well into 2022, so now is the time for pharmaceutical companies to take action in order to overcome the challenges self-administration brings about, and ensure that their technology puts them in the best position to create opportunities and benefits in this space. © 2022 TeknoScienze. All rights reserved.